Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing the FORTIFY phase 3 clinical trial data of BridgeBio's BBP-418 in Limb-girdle Muscular Dystrophy (LGMD2I/R9).

Ticker(s): BBIO

Who's the expert?

Institution: Mayo Clinic

Professor of Neurology at Mayo Clinic Rochester
Currently manages ~20 patients for limb-girdle muscular dystrophy type
Research focuses on muscular dystrophies and mitochondrial disorders causing muscle weakness

Interview Goal

To discuss the current treatment landscape and the potential of BBP-418, a Small Molecule being developed by BridgeBio for the treatment of limb-girdle muscular dystrophy type 2I/R9 (LGMD2I/R9).

Are You Interested In These Questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here To Join
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

5Hours Left to Join Project

Call Date: Nov 18, 2025
Call Time: 05:00 PM EST

Wall Street Time

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here To Join
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.